These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8264560)

  • 21. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder.
    Colabufo NA; Berardi F; Contino M; Perrone R; Tortorella V
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):106-12. PubMed ID: 12879208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
    Kung MP; Kung HF; Chumpradit S; Foulon C
    Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.
    John CS; Lim BB; Geyer BC; Vilner BJ; Bowen WD
    Bioconjug Chem; 1997; 8(3):304-9. PubMed ID: 9177835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
    Liu X; Nuwayhid S; Christie MJ; Kassiou M; Werling LL
    Eur J Pharmacol; 2001 Jun; 422(1-3):39-45. PubMed ID: 11430911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
    Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characteristics of hyperambulation induced by the sigma ligand (+)-3-PPP in rats.
    Hirotsu I; Koyama M; Honbo N; Ohno T
    Jpn J Pharmacol; 1994 May; 65(1):1-7. PubMed ID: 7916383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
    Garner SE; Kung MP; Foulon C; Chumpradit S; Kung HF
    Life Sci; 1994; 54(9):593-603. PubMed ID: 8114613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat.
    Gudelsky GA
    Eur J Pharmacol; 1995 Nov; 286(3):223-8. PubMed ID: 8608783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiropiperidines as high-affinity, selective sigma ligands.
    Chambers MS; Baker R; Billington DC; Knight AK; Middlemiss DN; Wong EH
    J Med Chem; 1992 May; 35(11):2033-9. PubMed ID: 1317923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sigma binding sites identified by [(3)H] DTG are elevated in aged Fischer-344 x Brown Norway (F1) rats.
    Wallace DR; Mactutus CF; Booze RM
    Synapse; 2000 Mar; 35(4):311-3. PubMed ID: 10657041
    [No Abstract]   [Full Text] [Related]  

  • 34. Signalling via rat dopamine D2-receptors expressed in mouse fibroblasts is not influenced by compounds binding to the sigma sites of these cells.
    Sommermeyer H; Dompert WU; Glaser T
    Cell Signal; 1993 Nov; 5(6):747-52. PubMed ID: 8130078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe.
    Pal A; Hajipour AR; Fontanilla D; Ramachandran S; Chu UB; Mavlyutov T; Ruoho AE
    Mol Pharmacol; 2007 Oct; 72(4):921-33. PubMed ID: 17622576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747.
    Paul R; Lavastre S; Floutard D; Floutard R; Canat X; Casellas P; Le Fur G; Brelière JC
    J Neuroimmunol; 1994 Jul; 52(2):183-92. PubMed ID: 7794416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.
    Helmeste DM; Tang SW; Bunney WE; Potkin SG; Jones EG
    Eur J Pharmacol; 1996 Oct; 314(3):R3-5. PubMed ID: 8957266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benz[f]isoquinoline analogues as high-affinity sigma ligands.
    Russell MG; Baker R; Billington DC; Knight AK; Middlemiss DN; Noble AJ
    J Med Chem; 1992 May; 35(11):2025-33. PubMed ID: 1317922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of sigma binding sites in guinea pig brain membranes.
    Karbon EW; Enna SJ
    Adv Exp Med Biol; 1991; 287():51-9. PubMed ID: 1662016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological evaluation of potent and enantioselective sigma 1, and sigma 2 ligands.
    Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Ronsisvalle G
    Farmaco; 2001 Mar; 56(3):181-9. PubMed ID: 11409325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.